ARNAS GAIXOTASUNAK
University Hospital of Lausanne
Lausana, SuizaUniversity Hospital of Lausanne-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823
2022
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
-
Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation
British journal of haematology, Vol. 197, Núm. 4, pp. 489-496
2021
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry
Journal of Internal Medicine, Vol. 287, Núm. 1, pp. 32-41
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
2017
-
Low discriminating power of the modified ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry
Thrombosis and Haemostasis, Vol. 117, Núm. 8, pp. 1630-1636
2015
-
Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism
Medicine (United States), Vol. 94, Núm. 32